Evidence map›Paper›PMID 31775512›Full record

ArticleACS infectious diseases2020

Mechanisms of Resistance Associated with the Inhibition of the Dehydration Step of Type II Fatty Acid Synthase in

Anna E Grzegorzewicz, Clifford Gee, Sourav Das, Jiuyu Liu, Juan Manuel Belardinelli, Victoria Jones, Michael R McNeil, Richard E Lee, Mary Jackson

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Antibiotic resistance inJAC-antimicrobial resistance · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Anna E GrzegorzewiczMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology , Colorado State University , Fort Collins , Colorado 80523-1682 , United States.
Clifford GeeDepartment of Chemical Biology & Therapeutics , St. Jude Children's Research Hospital , 262 Danny Thomas Place , Memphis , Tennessee 38105 , United States.
Sourav DasDepartment of Chemical Biology & Therapeutics , St. Jude Children's Research Hospital , 262 Danny Thomas Place , Memphis , Tennessee 38105 , United States.
Jiuyu LiuDepartment of Chemical Biology & Therapeutics , St. Jude Children's Research Hospital , 262 Danny Thomas Place , Memphis , Tennessee 38105 , United States.
Juan Manuel BelardinelliMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology , Colorado State University , Fort Collins , Colorado 80523-1682 , United States.
Victoria JonesMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology , Colorado State University , Fort Collins , Colorado 80523-1682 , United States.
Michael R McNeilMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology , Colorado State University , Fort Collins , Colorado 80523-1682 , United States.
Richard E LeeDepartment of Chemical Biology & Therapeutics , St. Jude Children's Research Hospital , 262 Danny Thomas Place , Memphis , Tennessee 38105 , United States.ORCID 0000-0002-2397-0443
Mary JacksonMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology , Colorado State University , Fort Collins , Colorado 80523-1682 , United States.ORCID 0000-0002-9212-0258
Colorado State University · USSt. Jude Children's Research Hospital · USLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

Mechanisms of Susceptibility and Resistance of Mycobacterium tuberculosis to Isoxyl and ThiacetazoneR21AI130929 · NIAID · COLORADO STATE UNIVERSITY · PI JACKSON, MARY · 2017 to 2018
$442k
NIAID NIH HHS R21 AI130929
6 · The paper itself

Abstract

Isoxyl (ISO) and thiacetazone (TAC) are two antitubercular prodrugs that abolish mycolic acid biosynthesis and kill

Indexed as

Antitubercular AgentsBacterial ProteinsDehydrationDrug Resistance, BacterialFatty Acid Synthase, Type IIMolecular Dynamics SimulationMutationMycobacterium tuberculosisMycolic AcidsAntitubercular AgentsBacterial ProteinsFatty Acid Synthase, Type IIMycolic AcidsdehydrataseFAS-IIisoxylMycobacteriummycolic acidsthiacetazonetuberculosis

Identifiers

PMID31775512
PMCPMC8078599
OpenAlexW2990415581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.